Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Sinan Karaaslan
29 years of experience
accreditations :
Clinic is certified :
The total cost of desmoid tumor treatment in Turkey depends on the specific diagnostic and therapeutic procedures. Initial consultations with a specialist cost $110, while a biopsy and histochemical analysis are $120 per block. Imaging procedures such as a thorax CT and abdominal ultrasound are priced at $330 and $230 respectively. Comprehensive blood tests, including hepatitis markers, amount to $960. The overall treatment plan is finalized after obtaining the test results and a doctor"s evaluation.
20 years of experience specializing in oncology – Dr. Solak trained at Hacettepe University Cancer Institute and MD Anderson Cancer Center.
Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Prof. Sezer Sağlam is a professor of medical oncology with extensive experience in gastrointestinal oncology at Gayrettepe Florence Nightingale Hospital.
Surgery is no longer the primary treatment for desmoid tumors in Turkey. Many oncology centers now recommend active surveillance as the first-line approach. Medical specialists prioritize non-invasive therapies like hormonal treatment or tyrosine kinase inhibitors to manage these tumors while minimizing the risk of recurrence.
Bookimed Expert Insight: Turkish oncology centers often implement findings from international research to reduce surgical intervention. Dr. Nail Paksoy at Medipol Bahçelievler has published research on the effectiveness of sorafenib for progressive desmoid tumors. This shift toward targeted drug therapy helps patients avoid complex surgeries while effectively controlling tumor growth.
Patient Consensus: Patients note it is important to find specialized sarcoma teams because surgery often carries a high risk of the tumor returning. Many find success managing the condition through long-term monitoring rather than rushing into an operation.
Desmoid tumors do not metastasize or spread to distant organs via the bloodstream or lymphatic system. These tumors are locally aggressive and invade surrounding muscle and nerves. While they are not malignant, they often recur in the same area after surgical removal.
Bookimed Expert Insight: Turkish oncology centers provide access to dual-specialized expertise often missing elsewhere. Dr. Nail Paksoy at Medipol Bahçelievler has specialized research in sorafenib for progressive cases. This focus on medical oncology rather than just surgery is vital because surgery frequently triggers further tumor growth.
Patient Consensus: Patients note that finding a dedicated sarcoma specialist is essential because these tumors behave uniquely. Many emphasize that watchful waiting is often safer than immediate surgery to avoid recurrence.
Treatment for a desmoid tumor in Turkey usually requires 7 to 14 days for surgery or initial evaluations. If your plan includes radiation therapy, your stay may extend to several weeks for daily sessions. Complex surgical cases require extra time for recovery and pathology results before travel.
Bookimed Expert Insight: Patient volume data highlights Turkey as a leading hub, with Medipol Mega University Hospital serving 1,000,000 patients annually. High-capacity centers like this often provide faster pathology results than smaller clinics. This efficiency can reduce your stay by 2 or 3 days during the critical diagnostic phase.
Patient Consensus: Patients note it is important to pack extra clothes and funds for unexpected buffer days. They suggest confirming if the schedule includes time for final imaging before booking return flights.
Turkey hosts specialist oncologists and multidisciplinary sarcoma teams managing rare desmoid tumors. Notable experts include Dr. Nail Paksoy at Medipol Bahçelievler University Hospital. He holds ESMO Board Certification. Leading JCI-accredited centers like Anadolu Medical Center and Istanbul Florence Nightingale provide specialized care.
Bookimed Expert Insight: Turkish oncology leads often specialize in specific medical sub-groups rather than just general cancer. Dr. Nail Paksoy at Medipol leads international clinical trials specifically focusing on desmoid tumor outcomes. This academic focus ensures patients receive protocols validated by global research standards.
Patient Consensus: Patients emphasize finding a doctor who prioritizes non-surgical observation over immediate resection. They recommend confirming pathology results with a multidisciplinary tumor board before starting treatment.
Yes, you must bring original pathology slides and imaging (CDs or USB drives) to Turkey. Desmoid tumors are rare and complex. Turkish specialists require these materials to verify your diagnosis. Having originals prevents repeat tests and saves time during your treatment planning.
Bookimed Expert Insight: Desmoid tumors require highly niche expertise often found at Anadolu Medical Center, which is affiliated with Johns Hopkins Hospital. Our data shows that top specialists like Assoc. Prof. Nail Paksoy at Medipol have published specific research on desmoid treatments. Bringing your original slides allows these experts to apply their specialized knowledge immediately, rather than waiting weeks for international transfers.
Patient Consensus: Patients emphasize that carrying original slides is vital because specialists value physical tissue over written reports when confirming rare cases. They suggest keeping everything in your carry-on to avoid delays and stressful administrative hurdles after arrival.
Top Turkish oncology centres prioritise active surveillance and systemic therapies over surgery to manage desmoid tumours. Specialists at JCI-accredited facilities, including Anadolu Medical Center and Memorial Health Group, follow international NCCN and ESMO protocols. They focus on non-invasive modalities like targeted therapies and precision radiotherapy to minimise recurrence.
Bookimed Expert Insight: Turkish oncology centres stand out by combining academic affiliation with high-volume surgical expertise. Anadolu Medical Center is affiliated with Johns Hopkins Medicine. This gives them access to global sarcoma protocols. Memorial Antalya Hospital treats 1.6 million patients annually, with 80% of cancer cases receiving TrueBeam STx radiotherapy. This volume allows multidisciplinary boards to accurately predict when to switch from surveillance to active intervention.
Patient Consensus: Patients emphasise that active surveillance is often the first step in Turkey because desmoids can spontaneously regress. Many find relief through oral targeted therapies like sorafenib. These can shrink tumours and quickly reduce pressure symptoms.
Anadolu Medical Center and Memorial Bahçelievler are leading Turkish hospitals for desmoid tumour treatment. These centres use multidisciplinary sarcoma boards to plan care. They offer therapies like MR-LINAC, targeted drugs, and precision surgery. Most facilities hold JCI accreditation for international safety.
Bookimed Expert Insight: Turkish oncology centres like Hisar Hospital Intercontinental stand out by offering MR-LINAC technology. This is vital for desmoid tumours because it allows specialists to track tumour movement in real-time. Since desmoids often sit near organs, this precision prevents damage to healthy tissue. Choosing a centre with MR-LINAC or TrueBeam STx allows the most conservative, tissue-sparing approach possible.
Patient Consensus: Patients note that finding a sarcoma specialist is more important than the hospital brand alone. They often suggest starting with a consultation at large academic centres in Istanbul or Ankara. This helps confirm whether surgery or monitoring is better.
Patients choose Turkey for desmoid tumour treatment because of high-volume oncology centres and multidisciplinary sarcoma expertise. Leading facilities hold JCI accreditation. They follow international NCCN and ESMO protocols. Specialist teams offer advanced diagnostics and targeted therapies. These are often unavailable or subject to long waiting lists elsewhere.
Bookimed Expert Insight: While many search for surgical options, Turkey’s strength lies in multidisciplinary boards. Here, medical and radiation oncologists collaborate. For example, Anadolu Medical Center integrates interventional oncology standards (IASIOS) into rare tumour management. This allows for tailored treatment plans. These may combine systemic therapies with precision radiation, rather than relying solely on surgery.
Patient Consensus: Patients note that finding a sarcoma specialist is vital. Desmoids require long-term management rather than a one-off cure. Many in Turkey find relief through systemic treatments like sorafenib or targeted radiation when surgery is not the primary option.